| 000 | 01632 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518071344.0 | ||
| 264 | 0 | _c20201117 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a1879-0720 | ||
| 024 | 7 |
_a10.1016/j.ejps.2019.105152 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Hui | |
| 245 | 0 | 0 |
_aThe impact of dopamine D _h[electronic resource] |
| 260 |
_bEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences _cFeb 2020 |
||
| 300 |
_a105152 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 |
_aDopamine D2 Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 | _aFluorine Radioisotopes |
| 650 | 0 | 4 | _aMacaca |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
| 650 | 0 | 4 |
_aQuinpirole _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
| 650 | 0 | 4 |
_aSalicylamides _xpharmacology |
| 650 | 0 | 4 |
_aVesicular Acetylcholine Transport Proteins _xmetabolism |
| 700 | 1 | _aLuo, Zonghua | |
| 700 | 1 | _aGu, Jiwei | |
| 700 | 1 | _aSu, Yi | |
| 700 | 1 | _aFlores, Hubert | |
| 700 | 1 | _aParsons, Stanley M | |
| 700 | 1 | _aZhou, Yun | |
| 700 | 1 | _aPerlmutter, Joel S | |
| 700 | 1 | _aTu, Zhude | |
| 773 | 0 |
_tEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences _gvol. 143 _gp. 105152 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejps.2019.105152 _zAvailable from publisher's website |
| 999 |
_c30325949 _d30325949 |
||